Furthermore, PA was found to decrease the elevated expression of SREBF1 and FASN proteins in the livers of NAFLD mice induced with a HFD (Figure 5C,E, p < 0.05). The gene discussed is FASN; the disease is metabolic dysfunction-associated steatotic liver disease.